Cargando…
Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells
Radiotherapy, in which X-rays are commonly used, is one of the most effective procedures for treating cancer. However, some cancer cells become resistant to radiation therapy, leading to poor prognosis. Therefore, a new therapeutic method is required to prevent cancer cells from acquiring radiation...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674178/ https://www.ncbi.nlm.nih.gov/pubmed/38004516 http://dx.doi.org/10.3390/pharmaceutics15112536 |
_version_ | 1785140767236292608 |
---|---|
author | Ito, Hiromu Shoji, Yoshimi Ueno, Megumi Matsumoto, Ken-ichiro Nakanishi, Ikuo |
author_facet | Ito, Hiromu Shoji, Yoshimi Ueno, Megumi Matsumoto, Ken-ichiro Nakanishi, Ikuo |
author_sort | Ito, Hiromu |
collection | PubMed |
description | Radiotherapy, in which X-rays are commonly used, is one of the most effective procedures for treating cancer. However, some cancer cells become resistant to radiation therapy, leading to poor prognosis. Therefore, a new therapeutic method is required to prevent cancer cells from acquiring radiation resistance. Photodynamic therapy (PDT) is a cancer treatment that uses photosensitizers, such as porphyrin compounds, and low-powered laser irradiation. We previously reported that reactive oxygen species (ROS) derived from mitochondria induce the expression of a porphyrin transporter (HCP1) and that laser irradiation enhances the cytotoxic effect. In addition, X-ray irradiation induces the production of mitochondrial ROS. Therefore, radioresistant cancer cells established with continuous X-ray irradiation would also overexpress ROS, and photodynamic therapy could be an effective therapeutic method. In this study, we established radioresistant cancer cells and examined the therapeutic effects and mechanisms with photodynamic therapy. We confirmed that X-ray-resistant cells showed overgeneration of mitochondrial ROS and elevated expression of HCP1, which led to the active accumulation of porphyrin and an increase in cytotoxicity with laser irradiation. Thus, photodynamic therapy is a promising treatment for X-ray-resistant cancers. |
format | Online Article Text |
id | pubmed-10674178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106741782023-10-26 Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells Ito, Hiromu Shoji, Yoshimi Ueno, Megumi Matsumoto, Ken-ichiro Nakanishi, Ikuo Pharmaceutics Article Radiotherapy, in which X-rays are commonly used, is one of the most effective procedures for treating cancer. However, some cancer cells become resistant to radiation therapy, leading to poor prognosis. Therefore, a new therapeutic method is required to prevent cancer cells from acquiring radiation resistance. Photodynamic therapy (PDT) is a cancer treatment that uses photosensitizers, such as porphyrin compounds, and low-powered laser irradiation. We previously reported that reactive oxygen species (ROS) derived from mitochondria induce the expression of a porphyrin transporter (HCP1) and that laser irradiation enhances the cytotoxic effect. In addition, X-ray irradiation induces the production of mitochondrial ROS. Therefore, radioresistant cancer cells established with continuous X-ray irradiation would also overexpress ROS, and photodynamic therapy could be an effective therapeutic method. In this study, we established radioresistant cancer cells and examined the therapeutic effects and mechanisms with photodynamic therapy. We confirmed that X-ray-resistant cells showed overgeneration of mitochondrial ROS and elevated expression of HCP1, which led to the active accumulation of porphyrin and an increase in cytotoxicity with laser irradiation. Thus, photodynamic therapy is a promising treatment for X-ray-resistant cancers. MDPI 2023-10-26 /pmc/articles/PMC10674178/ /pubmed/38004516 http://dx.doi.org/10.3390/pharmaceutics15112536 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ito, Hiromu Shoji, Yoshimi Ueno, Megumi Matsumoto, Ken-ichiro Nakanishi, Ikuo Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title | Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title_full | Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title_fullStr | Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title_full_unstemmed | Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title_short | Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells |
title_sort | photodynamic therapy for x-ray-induced radiation-resistant cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674178/ https://www.ncbi.nlm.nih.gov/pubmed/38004516 http://dx.doi.org/10.3390/pharmaceutics15112536 |
work_keys_str_mv | AT itohiromu photodynamictherapyforxrayinducedradiationresistantcancercells AT shojiyoshimi photodynamictherapyforxrayinducedradiationresistantcancercells AT uenomegumi photodynamictherapyforxrayinducedradiationresistantcancercells AT matsumotokenichiro photodynamictherapyforxrayinducedradiationresistantcancercells AT nakanishiikuo photodynamictherapyforxrayinducedradiationresistantcancercells |